Changing epidemiology of systemic fungal infections

Area of Science:

• Mycology
• Infectious Diseases
• Clinical Microbiology

Background:

• Candida and Aspergillus species are common causes of invasive fungal infections (IFIs).
• Emerging fungal pathogens, including Zygomycetes, Fusarium, and Scedosporium species, are increasingly identified in vulnerable patient populations.
• These include individuals with leukemia and bone marrow transplant recipients, highlighting evolving epidemiology of IFIs.

Purpose of the Study:

• To highlight the changing landscape of fungal pathogens causing IFIs.
• To emphasize the critical need for recognizing these emerging pathogens in specific patient groups.
• To underscore the importance of informed antifungal agent selection.

Main Methods:

• Review of current epidemiological trends in IFIs.
• Analysis of key factors influencing antifungal drug selection.
• Emphasis on pathogen identification and susceptibility patterns.

Main Results:

• While Candida and Aspergillus remain prevalent, other fungi are significant emerging pathogens.
• Opportunistic yeasts and molds are increasingly implicated in IFIs.
• Specific patient groups, like transplant recipients, are at higher risk.

Conclusions:

• Recognition of evolving fungal pathogen epidemiology is vital for patient care.
• Antifungal selection must consider patient type (e.g., solid-organ vs. stem-cell transplant), immunosuppression level, prior antifungal exposure, and pathogen susceptibility.
• A tailored approach is essential for managing IFIs caused by emerging fungal species.